As we approach the close of another remarkable year, Relisys Medical Devices extends heartfelt gratitude to all doctors, healthcare partners, and team members who have been part of our journey. Together, we strengthened cardiovascular innovation, improved patient outcomes, and made advanced therapies more accessible across India and beyond.
Celebrating Our 2025 Milestones
This year was truly transformative — a testament to our shared commitment to innovation, quality, and patient-centric care.
Landmark TAVI & TricValve Cases
Our continued success with the Vienna Aortic Valve SE and the TricValve Bicaval Valves System showcased procedural precision and reinforced our mission to redefine cardiac interventions. These achievements demonstrate how reliable, next-generation technologies can significantly improve patient lives.
Presence at Leading Conferences
Relisys proudly participated in several prestigious national and international cardiology conferences. Across each platform, we showcased our cutting-edge cardiovascular portfolio, engaged with global experts, and contributed to the evolving landscape of structural heart and interventional cardiology innovations.
Expanding Therapy Areas
The growing clinical adoption of our Pearl CB (Cutting Balloon) and Pearl DCB (Drug-Coated Balloon) highlighted the trust clinicians place in our devices. This year also marked the launch of MetaGraft AAA (Abdominal Aortic Stent Grafts) and MetaGraft TAA (Thoracic Aortic Stent Grafts)—both of which have been readily accepted by the medical fraternity for their role in managing life-threatening aortic conditions and improving patient survival.
Strengthening Our Purpose
At the core of every milestone is our belief that quality cardiovascular care should be accessible to all. Through continuous R&D, advanced manufacturing, and close collaboration with healthcare professionals, we are committed to delivering precision-engineered devices that empower clinicians and transform patient care.
A Global Step Forward: Relisys Goes to Egypt
A defining moment this year was the signing of an MoU to establish a state-of-the-art manufacturing facility in Egypt. The new facility will produce coronary vascular devices — including stents, balloons, and delivery accessories — to serve the Middle East and North Africa (MENA) region. This initiative reflects our larger mission to expand access, build local capacity and strengthen global healthcare ecosystems.
Sustainability & Social Responsibility
Our “Plastic-for-a-Tree” initiative on World Environment Day encouraged collective action toward sustainability, ending with a tree-planting drive at one of our factories.
On World Heart Day, we conducted a special awareness session on preventive heart health, reinforcing our dedication to education, wellness, and community care.
Elevate. Accelerate. 2025 🚀
Our FY 2025 theme — Elevate. Accelerate. — inspired teams to realign around bold ambitions and a clear roadmap for the future. With renewed purpose, we step into 2026 focused on innovation, collaboration, and better outcomes for patients worldwide.
A Heartfelt Thank You ❤️
Thank you, to the doctors who trust our devices, the partners who share our vision, and the teams who make it all possible. Here’s to new beginnings, stronger collaborations, and another year of transforming lives. Together, we’ll keep hearts beating stronger.
Wishing everyone a Healthy and Prosperous New Year 2026!